Stephan Bernstein, CEO of GreenRoc, details the PFS results for the new graphite processing plant. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksItaconix Plc Regulatory News (ITX)

Share Price Information for Itaconix Plc (ITX)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 157.50
Bid: 150.00
Ask: 165.00
Change: 0.00 (0.00%)
Spread: 15.00 (10.00%)
Open: 157.50
High: 157.50
Low: 157.50
Prev. Close: 157.50
ITX Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Interim Results

28 Sep 2021 07:00

RNS Number : 1435N
Itaconix PLC
28 September 2021
 

Itaconix plc

("Itaconix" or the "Company")

 

Half year results for the period ended 30 June 2021

 

 

Itaconix (AIM: ITX) (OTCQB: ITXXF), a leading innovator in plant-based specialty polymers used as essential ingredients in everyday consumer products, is pleased to announce its unaudited interim results for the six months ended 30 June 2021.

John R. Shaw, CEO of Itaconix, commented:

"We continue to build a diverse foundation of consumer products that rely on our ingredients to meet customer demands for performance, price, and sustainability. Progress with new and recurring orders from our growing customer base increased overall revenues compared to the first half of 2020 and expanded the use of our plant-based technology platform in the global low-carbon economy. I am especially excited that a major brand set a new standard for bio-based content by launching a new North American dishwashing detergent in February based on Itaconix® TSI™ 322.

Highlights

· First half revenues of $1.4 million were 26% higher than the first half of 2020. Due to customer ordering patterns, these first half revenues were 36% lower than in the second half of 2020.

· Gross profits were $0.5 million, representing an increase of 30% over the first half of 2020 and decrease of 30% over the second half of 2020.

· Gross profit margin was 38% compared to 35% for the full year of 2020, remaining in line with Company expectations for a specialty ingredient company.

· Adjusted EBITDA1 was a loss of $0.7 million, compared to a loss of $0.6 million for the same period in 2020, reflecting some increase in investment spending on new products and applications.

· Loss before taxes was $0.2 million, represented a decrease of 78% from losses of $0.8 million in both the first and second halves of 2020. Revaluation of the contingent consideration liability as a non-cash item contributed $0.5 million to this decrease. Forgiveness of the US PPP loan for Covid-19 government assistance contributed another $0.2 million to this decrease.

· Cash and cash equivalents as at 30 June 2021 was $1.4 million, compared to $1.4 million as at 31 December 2020.

· In June 2021, the Company completed an equity raise with gross proceeds of $1.5 million to fund general working capital needs and new product development.

· The Company received the London Stock Exchange's Green Economy Mark in recognition for its contributions to the global green economy.

Commenting on the outlook John R. Shaw, CEO added:

"Our revenue opportunities continue to grow in line with increasing recognition of the role our ingredients play in meeting demands from brands and retailers for more sustainable consumer products. Order volumes are recovering from the disruptions we experienced in the first half of the year, but we expect some continuation in market volatility through to the first half of next year. Underlying consumer demand for our products and new application developments are generating new customers and revenue potential for 2022."

1 Adjusted EBITDA is defined and reconciled to Operating loss in Note 4 of the Interim Report.

 

 

For further information please contact:

Itaconix plc

+1 603 775-4400

John R. Shaw / Laura Denner

Belvedere Communications

+44 (0) 20 3687 2756

John West / Llew Angus

finnCap

+44 (0) 20 7220 0500

Ed Frisby / Abigail Kelly / Milesh Hindocha (Corporate Finance)

Andrew Burdis / Sunila de Silva (ECM)

About Itaconix

Itaconix uses its proprietary plant-based polymer technology platform to produce and sell specialty ingredients that improve the safety, performance, and sustainability of consumer products. The Company's current ingredients are enabling and leading new generations of products in detergents, hygiene, and hair care. Itaconix's contributions to the global low carbon economy are recognised by the London Stock Exchange's Green Economy Mark.

www.itaconix.com

 

 

 

 

 

 

Chief Executive's Statement

Overview

Itaconix is using and growing its proprietary plant-based polymer technology platform to build a large, high-gross-margin, capital-efficient company that produces and sells key ingredients used in everyday consumer products. From detergents and air fresheners to shampoos and underarm deodorants, our ingredients are adding efficacy and sustainability to a growing range of consumer products that is creating a customer base for new and recurring revenues. The demand for new generations of consumer products continues to grow as the urgency to decarbonise our economies intensifies. Brands and retailers face increasing pressures from consumers and governments for more sustainable solutions, particularly within the 360 million households across Europe and North America.

Itaconix is pioneering new classes of plant-based polymers that enable new levels of performance, value, and sustainability across broad categories of consumer products. The first half of 2021 saw continued development of a strong foundation for realising the revenue potential in every household for our plant-based technology platform. We have a diverse and growing base of customers and products.

Operations

We are gaining more customers as our current polymers are adopted as key ingredients in breakthrough consumer products.

We are excited about the growth in our detergent customer base as important new brands use Itaconix® TSI™ 322 to produce new compact products with excellent consumer value and new levels of sustainability. We are particularly pleased that a major brand launched a dishwashing detergent in North America that set a new standard for plant-based content. With the recent announcement of our first order for Itaconix® TSI™ 322 in Europe, we expect our new EU customer to set a similar standard in Europe.

The increase in the detergent customer base did not translate into higher detergent revenues for the period. These revenues were flat compared to the same period in 2020 and lower than the second half of 2020 due to inventory adjustments and supply chain delays. Many brands and retailers reduced production to recalibrate inventories for normalized consumer demand after stockpiling product during the initial stages of the pandemic. Customer production levels were also reduced by limited supplies of certain other detergent components due to emergency plant shutdowns in Texas and Delaware and shipping delays from Asia to North America. We believe the underlying consumer demand for these products remain strong.

Our on-going development efforts in odour neutralisation are generating new applications, adoption by more brands, and increasing consumer demand from the success of leading brands. Strong demand for our odour neutralising polymers exceeded our expectations and resulted in revenues for the period that were higher than the same period in 2020 and ahead of the second half of 2020.

In hair care, our styling polymer enables both sustainability and new styling capabilities. Early success with specialty brands is generating both recurring orders and initial use by major brands. Hair care revenues for the period were less than the same period in 2020 and less than the second half of 2020 as shipments in the last part of 2020 were sufficient to meet customer needs during the lockdowns in North America and Europe. Underlying demand remains steady and order volumes are recovering.

On the production side, delivery costs and times for key raw materials for our polymers are increasing as suppliers continue to struggle with shipping delays caused by the pandemic and disruption throughout the supply chain. We have prudent stocks of raw materials and have worked successfully to pass on additional costs with product price increases to most of our customers.

LSE Green Economy Mark

Itaconix is demonstrating the ability to contribute to the decarbonisation of global economies with plant-based ingredients without compromising on performance or price. We were delighted to receive the London Stock Exchange's Green Economy Mark in recognition of this important milestone. This was awarded for our contributions to the green economy in the LSE's Advanced Materials industry sector. With increasing awareness of climate change, we look forward to working with our customers and other plant-based ingredient companies to decarbonise the global economy.

.

Funding

In June 2021, we raised $1.5 million in new funding through the placement of new ordinary shares by way of a direct subscription with one new institutional investor and one existing institutional shareholder, IP Group plc. The proceeds of the fundraise are being used for working capital purposes and new product development, including the certainty of the Company's raw material and finished goods supply chain.

Financial Results

Revenues of $1.4 million for the first half of the year were a 26% increase over the same period in 2020. These revenues were a 36% decrease on the second half of 2020 due to normal ordering for customer product launches in early 2021, some stockpiling in response to the pandemic in late 2020, and the inventory adjustments and supply delays in this period that are detailed above.

 

Odour control revenues in the first half of 2021 were higher than the same period in 2020 and the second half of 2020. Detergent revenues for the first half of 2021 were flat compared to the first half of 2020 and less than the second half of 2020, primarily reflecting strong customer orders to build inventory in the second half of 2020. Hair care revenues for the period were less than the same period in 2020 and the second half of 2020, again, due to the delivery of large orders into customer inventories toward the end of 2020.

 

Gross profits for the period were $0.5 million, representing gross profit margins of 38% compared to 37% for the same period in 2020 and 35% for the full year of 2020.

Adjusted EBITDA1 was a loss of $0.7 million, compared to a loss of $0.6 million for the same period in 2020, reflecting some increase in investment spending on new products and applications.

Loss before taxes was $0.2 million, representing a decrease of 78% from losses of $0.8 million in both the first and second halves of 2020. Revaluation of the contingent consideration liability as a non-cash item contributed $0.5 million to this decrease. Forgiveness of the US PPP loan for Covid-19 government assistance, as other income, contributed another $0.2 million to this decrease.

Net cash was $1.4 million at 30 June 2021 compared to $0.5 million at 30 June 2020 and $1.4 million at 31 December 2020.

Current Trading and Outlook

Itaconix is building a strong business base of recurring revenues from existing customers and new recurring revenues from new customers. Our revenue opportunities are growing in line with the increasing recognition of the role our ingredients play in meeting demands from brands and retailers for more sustainable consumer products. We expect continued success at turning our pipeline of customer projects into sizable new revenues, particularly in detergents and odour neutralisation.

Revenues for full year 2021 will depend on the timing of initial orders from new customers and applications launching in early 2022, and on the continued recovery in detergent and hair care volumes from the inventory adjustments and supply delays detailed above.

In summary, we are extremely pleased at the rate at which our ingredients are being incorporated into our customers' brands and expect significant further success in the next twelve months. We are seeing more opportunities to engage with customers and potential collaboration partners on new generations of consumer products using both current and new potential ingredients from our proprietary plant-based technology platform. Our emerging work on additional new products and applications is expected to further grow our customer base and revenue potential.

 

John R. Shaw

Chief Executive Officer

27 September 2021

 

Condensed consolidated income statement and statement of comprehensive income

For the six months ended 30 June 2021

Unaudited

Unaudited

6 Months to30 June 2021

6 Months to30 June 2020

Notes

$000

$000

Revenue

5

1,366

1,086

Cost of sales

(842)

(683)

Gross profit

524

403

Other income

4

183

71

Administrative expenses

(1,399)

(1,287)

Group operating loss

(692)

(813)

Exceptional income on movement of contingent consideration

6

514

-

Loss before tax

(178)

(813)

Taxation credit

(1)

(1)

Loss for the period

(179)

(814)

Other comprehensive income, net of income tax

Items that may be reclassified subsequently to profit or loss:

Exchange differences on translated foreign operations

(93)

110

Total comprehensive loss for the period

(272)

(704)

Basic and diluted loss per share

7

(0.04p)

(0.30p)

 

 

 

Condensed consolidated statement of financial position

As at 30 June 2021

Unaudited

Audited

As at

As at

30 June

31 December

2021

2020

Notes

$000

$000

Non-current assets

Property, plant and equipment

457

501

Right-of-use asset

645

746

1,102

1,247

Current assets

Inventories

1,358

1,361

Trade and other receivables

274

463

Cash and cash equivalents

3

1,378

1,448

3,010

3,272

Total assets

4,112

4,519

Financed by

Equity shareholders' funds

Equity share capital

5,873

5,718

Equity share premium

47,633

46,135

Own shares reserve

(5)

(5)

Merger reserve

31,343

31,343

Share based payment reserve

10,366

10,335

Foreign translation reserve

(304)

(211)

Retained losses

(94,119)

(93,940)

Total equity / (deficit)

787

(625)

Non-current liabilities

Contingent consideration

6

2,078

2,707

Note payable

-

51

Long-term lease liability

395

476

2,473

3,234

Current liabilities

Trade and other payables

499

1,404

Notes payable

-

132

Contingent consideration

151

146

Short-term lease liability

202

228

852

1,910

Total liabilities

3,325

5,144

Total equity and liabilities

4,112

4,519

 

Interim condensed consolidated statement of cash flows

For the six months ended 30 June 2021

Unaudited

Unaudited

6 Months to30 June 2021

6 Months to30 June 2020

 

 

$000

$000

Cash flows from operating activities

Operating loss before tax

(178)

(813)

Adjustments for:

Depreciation of property, plant and equipment

86

108

Depreciation of right-of-use asset

101

99

Gain on disposal of equipment

-

(15)

Share option charge

31

8

Revaluation of deferred consideration

(478)

-

Gain on foreign exchange

(93)

(57)

Taxation

(1)

(1)

Decrease / (increase) in inventories

4

(202)

Decrease in receivables

189

40

(Decrease) / increase in payables

(1,091)

496

Net cash (outflow) from operating activities

(1,430)

(337)

Cash flows from investing activities

Proceeds from sale of property, plant and equipment

-

20

Purchase of property, plant and equipment

(42)

-

Net cash (outflow) / inflow from investing activities

(42)

20

Cash flows from financing activities

Cash received from issuing share of stock, net

1,509

-

Proceeds from government secured debt

-

183

Lease payments

(88)

(183)

Interest expense on lease payments

(19)

11

Net cash inflow from financing activities

1,402

11

Net (outflow) in cash and cash equivalents

(70)

(306)

Cash and cash equivalents at beginning of the period

1,448

765

Cash and cash equivalents at end of the period

1,378

459

 

Notes of non-cash items

In April 2021, the Company issued 1,923,389 shares of stock to satisfy the 2020 contingent consideration payment of $146k.

In April 2021, the Group received forgiveness from the US Small Business Administration in the amount of $183k for the Covid-19 relief loan to support US employees.

Notes to the interim condensed consolidated financial statements

1. General information

These unaudited interim condensed financial statements of Itaconix plc for the six months ended 30 June 2021 were approved for issue in accordance with a resolution of the Board on 27 September 2021. Itaconix plc is a public limited company incorporated in the United Kingdom whose shares are traded on the AIM Market of the London Stock Exchange.

This half-yearly financial report is also available on the Group's website at https://itaconix.com/investor/reports-documents/.

2. Accounting policies

These interim consolidated financial statements have been prepared in accordance with UK adopted International Accounting Standards (collectively "IFRS"). They do not include all disclosures that would otherwise be required in a complete set of financial statements and should be read in conjunction with the 31 December 2020 ('2020') Annual Report. The financial information for the half years ended 30 June 2021 and 30 June 2020 does not constitute statutory accounts within the meaning of Section 434 (3) of the Companies Act 2006 and both periods are unaudited.

The annual financial statements of Itaconix Plc ('the Group') are prepared in accordance with IFRS. The comparative financial information for the year ended 31 December 2020 included within this report does not constitute the full statutory Annual Report for that period. The statutory Annual Report and Financial Statements for 2020 have been filed with the Registrar of Companies. The Independent Auditors' Report on the Annual Report and Financial Statements for the year ended 31 December 2020 was unqualified, did draw attention to a matter by way of emphasis, being going concern, and did not contain a statement under 498(2) - (3) of the Companies Act 2006.

The interim condensed consolidated financial statements are presented in US dollars and all values are rounded to the nearest thousand ($'000) except when otherwise indicated. The interim condensed consolidated financial statements are prepared on the historical cost basis except for contingent consideration which have been measured at fair value.

The Group has applied the same accounting policies and methods of computation in its interim consolidated financial statements as in its 31 December 2020 annual financial statements, except for those that relate to new standards and interpretations effective for the first time for periods beginning on (or after) 1 January 2021 and will be adopted in the 2021 financial statements. There are deemed to be no new and amended standards and/or interpretations that will apply for the first time in the next annual financial statements that are expected to have a material impact on the Group.

Going concern

This Interim Report has been prepared on the assumption that the business is a going concern. In reaching their assessment, the Directors have considered a period extending at least 12 months from the date of approval of this half-yearly financial report. This assessment has included consideration of the forecast performance of the business for the foreseeable future and the cash available to the Group. As such, the Directors have concluded that there exists a material uncertainty which may cast doubt as to the Group's ability to continue as a going concern. However, taking account of the Group's working capital at the date of this report, the Group's current revenues, and current shareholder authority to raise capital if needed, the Directors believe the Group will continue as a going concern for the foreseeable future. The interim financial statements do not include the adjustments that would be required if the Group were unable to continue as a going concern.

Risks and uncertainties

The principal risks and uncertainties facing the Group remain broadly consistent with the Principal Risks and Uncertainties reported in Itaconix plc's 31 December 2020 Annual Report.

 

 

3. Cash and cash equivalents

Unaudited

Audited

As at

As at

30 June

31 December

2021

 

2020

$000

$000

Cash at bank and in hand

1,378

1,448

1,378

1,448

 

4. Reconciliation of Operating Loss to Adjusted EBITDA

The detail below shows the reconciliation of operating loss to earnings before change in value of contingent consideration, government loan forgiveness for Covid-19 relief, interest, taxes, depreciation and amortisation (Adjusted EBITDA).

 

Unaudited6 Months to30 June 2021

Unaudited6 Months to30 June 2020

$000

$000

Loss for the period

(179)

(814)

Revaluation of contingent consideration

(514)

-

Other Income - government loan forgiveness

(183)

-

Taxes

1

1

Depreciation and amortisation

187

207

Adjusted EBITDA

(688)

(606)

 

 

5. Segmental analysis

Revenue by business segment:

The Group has one segment, the Specialty Ingredients segment, which designs and manufactures proprietary specialty polymers to meet customers' needs in the personal and consumer health care, homecare and industrial sectors. This segment makes up the continuing operations above.

Net assets of the Group are attributable solely to the UK and US.

 

 

 

Unaudited

6 months to

30 June 2021

Unaudited

6 months to

30 June 2020

$000

$000

Revenue

Sale of goods

1,366

1,086

Segment revenue

1,366

1,086

Results

Depreciation and amortisation

187

207

Segment loss

(210)

(822)

Operating assets

4,112

2,865

Operating liabilities

3,325

4,588

Other disclosure:

Capital expenditure*

42

Nil

 

*Capital expenditure consists of additions of property, plant and equipment, and intangible assets.

 

 

Geographical information

 

Revenues

Net assets

Unaudited

Unaudited

Unaudited

Audited

Six Months to

30 June 2021

Six Months to

30 June 2020

Six Months to

30 June 2021

Year to31 December 2020

$000

$000

$000

$000

Europe

64

93

(635)

(1,557)

North America

1,302

993

1,422

932

1,366

1,086

787

(625)

The revenue information above is based on the location of the customer.

 

6. Contingent consideration

$'000

As at 31 December 2020 (Audited)

2,853

Movement in fair value and discounting unwind

(514)

Share issuance for contingent consideration 2020

(146)

Movement in foreign exchange

36

As at 30 June 2021 (Unaudited)

2,229

During 2018, in conjunction with the fund raise, a restructuring of the contingent consideration was executed. The contingent consideration was restructured into two components:

· A one-time issue of 15 million new Itaconix plc shares to the Sellers.

· The continuation of the previous contingent consideration mechanism (i.e. up to $6m in shares), but with the window of time for potential achievement expanded to the end of 2022 (from the end of 2020) and including all the revenues of the Group (which are primarily from products based on the acquired technology in any event).

It should also be noted that the second component summarised above was intended to serve as an incentive programme for the two members of management (John Shaw and Yvon Durant) who were also Sellers and are entitled to 63% of the total contingent consideration. Accordingly, they were not eligible for any cash bonus or other share incentive programme until the end of 2020. Simultaneously, the merger agreement with the former shareholders of Itaconix Corporation and related agreements were amended to remove various restrictive clauses, including minimum funding requirements and employment terms.

Based on the share price at the execution of the restructuring agreement in 2018, the 15m shares had a value of £0.3m which was expensed immediately.

In respect of 2021, the deferred consideration for the period was valued using a discounted cash flow-based assessment of the expected sales of the relevant products extracted from a recent management prepared forecast, consistent with the approach in prior years. A discount rate of 10.9% was used. The valuation includes elements which are unobservable and which have a significant impact on the fair value. Accordingly, contingent consideration is classified as Level 3 fair value measurement.

The value of the adjusted contingent component using a recent management prepared forecast and assumptions as above is $2.2m (31 December 2021 - $2.9m)

As a result of the changed revenue forecasts, earn out period, and discount rate from the original value assessments, the contingent consideration at 30 June 2021 was reduced to $2.2m. Sensitivity analysis was also performed, summarised as follows:

· If the sales in the period 2021 to 2022 were reduced by $1.0m, the fair value would be reduced by approximately $0.4m

· A 1% increase in the discount rate would reduce the fair value by $44k

Since the forecasts used were a conservative base case, the computed fair value was deemed appropriate.

 

7. Weighted-average number of ordinary shares

Unaudited

Unaudited

6 Months to

30 June 2021

6 Months to

30 June 2020

Weighted average number of ordinary shares for the

 purposes of basic and diluted loss per share ('000)

434,050

269,130

 

8. Events after the reporting period

There were no material post balance sheet events.

 

9. Cautionary statement

This document contains certain forward-looking statements relating to Itaconix plc. The Company considers any statements that are not historical facts as "forward-looking statements". They relate to events and trends that are subject to risk and uncertainty that may cause actual results and the financial performance of the Company to differ materially from those contained in any forward-looking statement. These statements are made by the Directors in good faith based on information available to them and such statements should be treated with caution due to the inherent uncertainties, including both economic and business risk factors, underlying any such forward-looking information.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
IR FZGZLFNVGMZZ
Date   Source Headline
29th Apr 20247:00 amRNSLaunch of two plant-based performance ingredients
19th Apr 20247:00 amRNSGrants of Options & PDMR dealings
15th Apr 20247:00 amRNSPreliminary Results and Notice of AGM
8th Apr 20247:00 amRNSNotice of Results
2nd Apr 20247:00 amRNSTrading Statement
27th Feb 20247:00 amRNSTrading Update
9th Feb 20247:00 amRNSAppointment of Non-Executive Director
26th Jan 20247:00 amRNSAppointment: Nominated Adviser and Sole Broker
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
15th Dec 20237:00 amRNSDirector/PDMR Shareholding
7th Dec 20237:00 amRNSTrading Update
30th Oct 20237:00 amRNSDirector/PDMR Shareholding
26th Oct 20235:28 pmRNSDirector/PDMR Shareholding
19th Oct 20235:08 pmRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSDirector/PDMR Shareholding
5th Oct 202311:01 amRNSHoldings in Company
12th Sep 20237:00 amRNSHalf year results
5th Sep 20237:00 amRNSNotice of Interim Results and Presentations
22nd Aug 20237:00 amRNSShare Consolidation & Total Voting Rights
15th Aug 20237:00 amRNSShare Consolidation
12th Jul 20237:00 amRNSTrading Update
28th Jun 202312:29 pmRNSAGM Statement
5th Jun 20237:00 amRNSFinal Results
24th May 20237:00 amRNSNotice of Final Results, Briefings, and AGM
25th Apr 20237:00 amRNSAppointment of Joint Corporate Broker
2nd Mar 20233:25 pmRNSTR-1
1st Mar 20237:00 amRNSAward from Frost & Sullivan
28th Feb 20236:03 pmRNSTR-1
28th Feb 20235:04 pmRNSTR-1
28th Feb 20233:09 pmRNSTR-1
23rd Feb 20237:00 amRNSTR-1
22nd Feb 202312:28 pmRNSResults of Open Offer, GM and Total Voting Rights
15th Feb 20237:00 amRNSInvestor Presentation following GM on 22 Feb 2023
3rd Feb 20237:00 amRNSPlacing, Subscription and Open Offer; Notice of GM
5th Jan 20237:00 amRNSBoard Change
6th Dec 20224:40 pmRNSSecond Price Monitoring Extn
6th Dec 20224:35 pmRNSPrice Monitoring Extension
5th Oct 20227:00 amRNSItaconix and Brenntag Promote Sustainable Cleaning
14th Sep 20227:00 amRNSHalf year results
13th Sep 202211:05 amRNSSecond Price Monitoring Extn
13th Sep 202211:00 amRNSPrice Monitoring Extension
7th Sep 20227:00 amRNSNotice of Results
5th Sep 20227:00 amRNSItaconix and Croda Renew Supply Agreement
20th Jul 20227:00 amRNSBoard Change
13th Jul 20227:00 amRNSTrading Update
5th Jul 20227:00 amRNSDirectorate Change
1st Jul 20222:37 pmRNSResult of AGM
1st Jul 20229:00 amRNSPrice Monitoring Extension
1st Jul 20227:00 amRNSAGM Statement and Notice of Capital Markets Event
29th Jun 20227:00 amRNSNotice of Capital Markets Webinar

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.